Wise K S, Kim M F, Theiss P M, Lo S C
Department of Molecular Microbiology & Immunology, School of Medicine, University of Missouri-Columbia 65212.
Infect Immun. 1993 Aug;61(8):3327-33. doi: 10.1128/iai.61.8.3327-3333.1993.
The wall-less procaryote Mycoplasma fermentans is currently being examined as an agent potentially associated with human disease, including infectious processes affecting immunocompromised individuals. To delineate and understand the interactions of M. fermentans with its host, specific membrane surface components were characterized as markers for detecting the organism and for assessing heterogeneity in antigenic surface architecture within this mycoplasma species. Detergent phase fractionation of metabolically labeled organisms of type strain PG18 identified a family of prominent integral membrane proteins; several of these labeled with 35S-cysteine and 3H-palmitate, which are characteristics of procaryotic lipoproteins. Specific monoclonal and polyclonal antibodies raised to strain PG18 components further distinguished seven of these membrane proteins, which were localized on the organism's surface by monitoring their selective susceptibility during trypsin treatment of intact cells. With these antibodies, Western immunoblot profiles of surface membrane antigens expressed on strain PG18 were compared with those expressed on the recently identified Incognitus strain of M. fermentans, as well as with several other human and animal mycoplasma species. While the antibodies were specific for M. fermentans, marked differences were observed between the strains in the size of one surface lipoprotein and in the apparent levels of several antigens expressed in the cultured populations analyzed. Some monoclonal antibodies to strain PG18 and a previously described monoclonal antibody to strain Incognitus showed apparent selectivity for the strain used for immunization. Monoclonal antibodies developed here recognize stable epitopes defining a family of surface lipoproteins and provide critical tools to determine the basis of surface variation in this mycoplasma species and to assess the location and antigenic phenotypes of organisms in the human host.
无细胞壁的原核生物发酵支原体目前正作为一种可能与人类疾病相关的病原体进行研究,这些疾病包括影响免疫功能低下个体的感染过程。为了描述和理解发酵支原体与其宿主之间的相互作用,对特定的膜表面成分进行了表征,作为检测该生物体以及评估该支原体物种抗原表面结构异质性的标志物。对代谢标记的PG18型菌株的生物体进行去污剂相分级分离,鉴定出一族突出的整合膜蛋白;其中几种用35S-半胱氨酸和3H-棕榈酸标记,这是原核生物脂蛋白的特征。针对PG18菌株成分产生的特异性单克隆抗体和多克隆抗体进一步区分了其中七种膜蛋白,通过监测完整细胞在胰蛋白酶处理过程中的选择性敏感性,确定它们位于生物体表面。利用这些抗体,将PG18菌株表面膜抗原的Western免疫印迹图谱与最近鉴定的发酵支原体隐种菌株以及其他几种人和动物支原体物种所表达的图谱进行了比较。虽然这些抗体对发酵支原体具有特异性,但在所分析的培养群体中,各菌株在一种表面脂蛋白的大小和几种抗原的表观水平上存在明显差异。一些针对PG18菌株的单克隆抗体和先前描述的针对隐种菌株的单克隆抗体对用于免疫的菌株表现出明显的选择性。这里开发的单克隆抗体识别定义表面脂蛋白家族的稳定表位,并为确定该支原体物种表面变异的基础以及评估人类宿主中生物体的位置和抗原表型提供了关键工具。